Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.

OBJECTIVE: Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) can present with a broad spectrum of signs and symptoms. The relative effects of different manifestations on health-related quality of life (HRQOL) are unknown. METHODS: We conducted an individual patient data meta-analysis o...

Detaylı Bibliyografya
Asıl Yazarlar:	Walsh, M, Mukhtyar, C, Mahr, A, Herlyn, K, Luqmani, R, Merkel, P, Jayne, DR
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2011

Benzer Materyaller

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Yazar:: Mukhtyar, C, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
Yazar:: Mukhtyar, C, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Yazar:: Flossmann, O, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
Yazar:: Mukhtyar, C, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
Yazar:: Robson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
Yazar:: Morishita, K, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
Yazar:: Robson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies
Yazar:: E. N. Vorkel, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
Yazar:: E. N. Vorkel, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
Yazar:: Megan M. Sullivan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Yazar:: Ulrich Specks, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
Yazar:: De Groot, K, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
Yazar:: Saket Jha, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Yazar:: Katarzyna Wawrzycka-Adamczyk, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
Yazar:: Deep Shikha, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
Yazar:: Sunil Kapur, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis
Yazar:: Durga Prasanna Misra, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Yazar:: Weiwei Hao, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
Yazar:: Noah Huizenga, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
Yazar:: T V Beketova
Baskı/Yayın Bilgisi: (2018-05-01)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
Yazar:: Weiran Li, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
Yazar:: Yoon Kook Kim, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

A Tangled Autoimmune Trio: Multiple Sclerosis, Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antineutrophil Cytoplasmic Antibody Vasculitis
Yazar:: Rajaie Namas, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.
Yazar:: Sourabh Chand, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis
Yazar:: Pil Gyu Park, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Health-related quality of life after Rituximab treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis
Yazar:: Iva Parvova, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
Yazar:: Talks, S, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

Antineutrophil Cytoplasmic Antibody Vasculitis after Coronary Artery Bypass Grafting
Yazar:: Dwight D. Harris, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in a patient with diffuse scleroderma
Yazar:: B N Shiva Prasad, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
Yazar:: O. N. Egorova, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis
Yazar:: Kunal Chandwar, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
Yazar:: Zdenka Hruskova, ve diğerleri
Baskı/Yayın Bilgisi: (2020-02-01)

Antineutrophil cytoplasmic antibody vasculitis causing skull base inflammation and aortitis
Yazar:: Boby Varkey Maramattom, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
Yazar:: Jamie R. Felzer, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China
Yazar:: Xiang-Yu Han, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Treatment of severe perinuclear antineutrophil cytoplasmic antibody–associated vasculitis with efgartigimod
Yazar:: Afsoon Ghafari-Saravi, BS, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Health-related quality of life in patients with ANCA-associated vasculitis: a pooled analysis of four randomized clinical trials
Yazar:: Walsh, M, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Antineutrophil cytoplasmic antibodies
Yazar:: G.D. Sebastiani
Baskı/Yayın Bilgisi: (2011-06-01)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
Yazar:: de Groot, K, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis
Yazar:: Chand, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)